Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Prepaid Assets of $7.9 million for Q1 2026, up 965.14% year-over-year from $740000.0 in Q1 2025, and up 396.97% quarter-over-quarter from $1.6 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Prepaid Assets data on file, last reported at $7.9 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $7.9 million, up 965.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 965.14% YoY), and the FY2025 annual result was $1.6 million, up 53.53% from the prior year.
- Prepaid Assets grew to $7.9 million in Q1 2026 per OLMA's latest filing, from $1.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.9 million in Q1 2026 and troughed at $78000.0 in Q3 2022.
- A 5-year average of $2.1 million and a median of $1.0 million in 2024 frame the typical range for Prepaid Assets.
- On a YoY basis, Prepaid Assets climbed as much as 1768.82% in 2022 and fell as far as 96.65% in 2022.
- A 5-year view of Prepaid Assets shows it stood at $1.7 million in 2022, then surged by 170.77% to $4.7 million in 2023, then sank by 78.05% to $1.0 million in 2024, then surged by 53.53% to $1.6 million in 2025, then surged by 396.97% to $7.9 million in 2026.
- Business Quant data shows OLMA's Prepaid Assets at $7.9 million in Q1 2026, $1.6 million in Q4 2025, and $288000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.88 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 5.81 Mn |
| Mar 31, 2025 | 740,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 384,000.00 |
| Jun 30, 2023 | 804,000.00 |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 1.74 Mn |
| Sep 30, 2022 | 78,000.00 |
| Jun 30, 2022 | 836,000.00 |
| Mar 31, 2022 | 467,000.00 |
| Dec 31, 2021 | 93,000.00 |
| Sep 30, 2021 | 2.33 Mn |
| Jun 30, 2021 | 2.71 Mn |